Investment Type: Venture Capital
Mentions in press and media 4
| Date | Title | Description |
| 22.12.2021 | Aptamer IPO: the next Biotech stock to watch? | Biotech stock Aptamer is launching its IPO on 22 December. Is this the next Biotech stock to watch? |
| 18.09.2020 | Vedanta Biosciences taps Big Pharma vet Jeffrey Silber as CMO; Robert Doebele leaves behind teaching post at Colorado to focus on CSO job at Rain Therapeutics | Jeffrey Silber → A Big Pharma vet has joined Cambridge, MA upstart Vedanta Biosciences to help develop and expand on its microbiome-derived bacteria portfolio. Jeffrey Silber signed on as CMO of Vedanta after 4 years a... |
| 08.06.2020 | Microbiotica to collaborate with CRUK and CUH in landmark cancer microbiome study | CIC portfolio company Microbiotica to collaborate with Cancer Research UK and Cambridge University Hospitals in landmark cancer microbiome study Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build ... |
| 27.03.2019 | Cancer Research UK, Lifearc and Ono Pharma Form Cancer Immunotherapy Alliance | New immunotherapy drug targets for cancer will be progressed through a multimillion-pound drug discovery alliance announced today (Wednesday) between Cancer Research UK, LifeArc and Ono Pharmaceutical Co., Ltd. The multi-year partnership b... |